Company logo Company name logo
Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.     |     Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors.     |     KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |     ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
tiker sep
plus stop minus
 
 
Astal Laboratories LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:512600NSE Symbol: Not ListedP/E(TTM):31.53
ISIN Demat:INE307N01014Div & Yield %:0EPS(TTM):2.22
Book Value(Rs):76.1385762Market Cap (rupee Cr.):306.59Face Value(Rs):10
    
Date Headline
07-Sep-26 Astal Laboratories AGM scheduled
01-Sep-26 Astal Laboratories announces board meeting date
15-Aug-26 Astal Laboratories standalone net profit rises 77.51% in the June 2026 quarter
10-Aug-26 Astal Laboratories to conduct board meeting
01-Jun-26 Astal Laboratories consolidated net profit rises 180.29% in the March 2026 quarter
26-May-26 Astal Laboratories to convene board meeting
15-Feb-26 Astal Laboratories standalone net profit declines 5.22% in the December 2025 quarter
11-Feb-26 Astal Laboratories to conduct board meeting
17-Nov-25 Astal Laboratories standalone net profit rises 29.00% in the September 2025 quarter
12-Nov-25 Astal Laboratories to declare Quarterly Results
<< < 1 2 > >>